JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ko Bando
Mark W. Turrentine
Thomas G. Sharp
Thomas X. Aufiero
Kyung Sun
John W. Brown
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bando, K.
Right arrow Articles by Brown, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bando, K.
Right arrow Articles by Brown, J. W.

J Thorac Cardiovasc Surg 1996;112:1600-1609
© 1996 Mosby, Inc.


SURGERY FOR CONGENITAL HEART DISEASE

PULMONARY HYPERTENSION AFTER OPERATIONS FOR CONGENITAL HEART DISEASE: ANALYSIS OF RISK FACTORS AND MANAGEMENT

Ko Bando, MD, Mark W. Turrentine, MD, Thomas G. Sharp, MD, Yasuo Sekine, MD, Thomas X. Aufiero, MD, Kyung Sun, MD, Eri Sekine, BS, MPH, John W. Brown, MD

From the Section of Cardiothoracic Surgery, James W. Riley Hospital for Children and Indiana University Medical Center, Indianapolis, Ind.

Received for publication May 6, 1996 Revisions requested June 26, 1996; revisions received July 29, 1996 Accepted for publication July 31, 1996. Address for reprints: Ko Bando, MD, Section of Cardiothoracic Surgery, Indiana University Medical Center, 545 Barnhill Dr., EM 215, Indianapolis, IN 46202-5123.

Abstract

Background: Management of pulmonary hypertension, a potentially fatal complication of operations to correct congenital heart disease, has evolved through the last 15 years. Monitoring of pulmonary arterial pressure and mixed venous saturation became available, and prophylactic use of{alpha}-blockers and other vasodilators increased. This study examines risk factors for morbidity and mortality from pulmonary hypertension after operations to correct congenital heart disease and evaluates the impact of management changes on outcomes.
Methods: By means of multivariable logistic regression analysis, 880 high-risk patients with congenital heart disease (of 2484 patients undergoing cardiopulmonary bypass between January 1980 and December 1994) were analyzed to determine which were at risk for postoperative pulmonary hypertension and its associated morbidity and mortality.
Results: Patients with atrioventricular canal (n = 182), truncus arteriosus (n = 47), total anomalous pulmonary venous connection (n = 90), transposition of great arteries (n = 97), hypoplastic left heart syndrome (n = 50), and ventricular septal defect (n = 414) demonstrated a higher risk of postoperative pulmonary hypertension. By multivariable logistic regression, preoperative pulmonary hypertension (p < 0.0001), absence of mixed venous saturation monitoring (p < 0.0001), and absence of prophylactic{alpha}-blockade (p = 0.0004) significantly increased postoperative pulmonary hypertension. Preoperative pulmonary hypertension (p < 0.001) and absence of prophylactic{alpha}-blockers (p = 0.0004) were significant risk factors for in-hospital death related to pulmonary hypertension. Repair at older age (except in the case of total anomalous pulmonary venous connection) was a significant risk for postoperative pulmonary hypertension (p = 0.03).
Conclusion: Mixed venous saturation monitoring and{alpha}-receptor blockade reduced the incidence of pulmonary hypertension after operations for congenital heart disease. Early definitive repair reduced morbidity and mortality from postoperative pulmonary hypertension. (J THORACCARDIOVASCSURG1996;112:1600-9)




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
J. E. Lee, S. C. Hillier, and C. A. Knoderer
Use of Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide in Children With Pulmonary Hypertension Following Surgery for Congenital Heart Disease
J Intensive Care Med, September 1, 2008; 23(5): 329 - 334.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Zhang, S. Wu, J. Liang, G. Zhang, G. Jiang, M. Zhou, and X. Li
Unidirectional Monovalve Homologous Aortic Patch for Repair of Ventricular Septal Defect With Pulmonary Hypertension
Ann. Thorac. Surg., June 1, 2007; 83(6): 2176 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. J. Taylor, G. Derrick, A. McEwan, S. G. Haworth, and M. R. J. Sury
Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension
Br. J. Anaesth., May 1, 2007; 98(5): 657 - 661.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. A. Seifert, D. L. Howard, J. H. Silber, and D. R. Jobes
Female gender increases the risk of death during hospitalization for pediatric cardiac surgery
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 668 - 675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-F. Lam, T. E. Peterson, A. J. Croatt, K. A. Nath, and Z. S. Katusic
Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2334 - H2341.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Gorenflo, M. V. Ullmann, K. Eitel, J. Gross, W. Fiehn, S. Hagl, and J. Dreyhaupt
Plasma L-Arginine and Metabolites of Nitric Oxide Synthase in Patients With Left-To-Right Shunt After Intracardiac Repair
Chest, April 1, 2005; 127(4): 1184 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. W. Lee, B. Ovadia, A. Azakie, S. Salas, J. Goerke, J. R. Fineman, and J. A. Gutierrez
Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of life
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1237 - L1243.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. G. Fischer, H. V. Aken, and H. Burkle
Management of Pulmonary Hypertension: Physiological and Pharmacological Considerations for Anesthesiologists
Anesth. Analg., June 1, 2003; 96(6): 1603 - 1616.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Schulze-Neick, J. Li, J. A. Reader, L. Shekerdemian, A. N. Redington, and D. J. Penny
The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease
J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 435 - 441.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Lindberg, A. K. Olsson, P. Jogi, and C. Jonmarker
How common is severe pulmonary hypertension after pediatric cardiac surgery?
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. Bushman
Essentials of Nitric Oxide for the Pediatric (Cardiac) Anesthesiologist
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 79 - 90.
[Abstract] [PDF]


Home page
HeartHome page
B Prendergast, D E Newby, L E Wilson, D J Webb, and P S Mankad
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
Heart, October 1, 1999; 82(4): 505 - 508.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Nagashima, U. Stock, G. Nollert, J. Sperling, D. Shum-Tim, S. Hatsuoka, and J. E. Mayer Jr
Effects of cyanosis and hypothermic circulatory arrest on lung function in neonatal lambs
Ann. Thorac. Surg., August 1, 1999; 68(2): 499 - 504.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. K. Choudhary, A. Bhan, R. Sharma, A. Mathur, B. Airan, A. Saxena, S. S. Kothari, R. Juneja, and P. Venugopal
Repair of total anomalous pulmonary venous connection in infancy: experience from a developing country
Ann. Thorac. Surg., July 1, 1999; 68(1): 155 - 159.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. M. Novick, A. T. Gurbuz, D. C. Watson, V. V. Lazorishinets, A. N. Perepeka, I. Malcic, B. Marinovic, B. S. Alpert, and T. G. DiSessa
Double patch closure of ventricular septal defect with increased pulmonary vascular resistance
Ann. Thorac. Surg., November 1, 1998; 66(5): 1533 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Bando, M. W. Turrentine, P. Vijay, T. G. Sharp, Y. Sekine, B. J. Lalone, L. Szekely, and J. W. Brown
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease
Ann. Thorac. Surg., September 1, 1998; 66(3): 821 - 828.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Vijay, L. Szekely, T. G. Sharp, A. Miller, K. Bando, and J. W. Brown
Adrenomedullin in patients at high risk for pulmonary hypertension
Ann. Thorac. Surg., August 1, 1998; 66(2): 500 - 505.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Katsumata, A. Shinfeld, and S. Westaby
Temporary Aorto-Pulmonary Shunt for Pulmonary Hypertension After Truncus Arteriosus Repair
Ann. Thorac. Surg., June 1, 1998; 65(6): 1764 - 1765.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Bando, P. Vijay, M. W. Turrentine, T. G. Sharp, L. J. Means, G. J. Ensing, B. J. Lalone, Y. Sekine, L. Szekely, and J. W. Brown
Dilutional And Modified Ultrafiltration Reduces Pulmonary Hypertension After Operations For Congenital Heart Disease: A Prospective Randomized Study
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 517 - 527.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The American Association for Thoracic Surgery.